Virtus Fund Advisers LLC grew its holdings in shares of Core Laboratories (NYSE:CLB) by 3.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 414,825 shares of the oil and gas company’s stock after buying an additional 12,650 shares during the quarter. Virtus Fund Advisers LLC’s holdings in Core Laboratories were worth $45,444,000 at the end of the most recent reporting period.
Other large investors have also modified their holdings of the company. Cubist Systematic Strategies LLC bought a new stake in Core Laboratories during the 2nd quarter worth about $474,000. Janus Henderson Group PLC lifted its position in Core Laboratories by 105.2% during the 3rd quarter. Janus Henderson Group PLC now owns 10,264 shares of the oil and gas company’s stock worth $1,013,000 after buying an additional 5,262 shares in the last quarter. Marble Harbor Investment Counsel LLC lifted its position in Core Laboratories by 4.9% during the 3rd quarter. Marble Harbor Investment Counsel LLC now owns 10,976 shares of the oil and gas company’s stock worth $1,083,000 after buying an additional 510 shares in the last quarter. Nomura Holdings Inc. bought a new stake in Core Laboratories during the 2nd quarter worth about $426,000. Finally, New York State Teachers Retirement System bought a new stake in Core Laboratories during the 3rd quarter worth about $632,000.
Several research firms have recently weighed in on CLB. TheStreet upgraded shares of Core Laboratories from a “c” rating to a “b-” rating in a research note on Thursday, February 1st. Royal Bank of Canada set a $125.00 price objective on shares of Core Laboratories and gave the stock a “buy” rating in a research note on Tuesday, January 30th. Zacks Investment Research upgraded shares of Core Laboratories from a “sell” rating to a “hold” rating in a research note on Wednesday, November 1st. Scotiabank set a $136.00 price objective on shares of Core Laboratories and gave the stock a “hold” rating in a research note on Wednesday, October 25th. Finally, ABN Amro upgraded shares of Core Laboratories from a “hold” rating to a “buy” rating in a research note on Wednesday, October 25th. Three research analysts have rated the stock with a sell rating, eight have given a hold rating and four have given a buy rating to the company’s stock. Core Laboratories presently has an average rating of “Hold” and a consensus price target of $111.70.
Core Laboratories (NYSE CLB) opened at $106.43 on Monday. Core Laboratories has a 52 week low of $86.55 and a 52 week high of $121.39. The company has a market cap of $4,700.41, a PE ratio of 53.22 and a beta of 1.44. The company has a quick ratio of 1.66, a current ratio of 1.98 and a debt-to-equity ratio of 1.53.
Core Laboratories (NYSE:CLB) last announced its quarterly earnings results on Wednesday, January 31st. The oil and gas company reported $0.58 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.58. Core Laboratories had a net margin of 12.60% and a return on equity of 58.25%. The business had revenue of $172.00 million for the quarter, compared to analyst estimates of $171.92 million. During the same quarter in the prior year, the business earned $0.41 EPS. Core Laboratories’s quarterly revenue was up 15.1% on a year-over-year basis. equities analysts forecast that Core Laboratories will post 2.67 earnings per share for the current year.
The business also recently declared a quarterly dividend, which was paid on Friday, February 16th. Investors of record on Friday, January 26th were paid a $0.55 dividend. The ex-dividend date of this dividend was Thursday, January 25th. This represents a $2.20 dividend on an annualized basis and a yield of 2.07%. Core Laboratories’s dividend payout ratio (DPR) is currently 117.02%.
COPYRIGHT VIOLATION WARNING: This news story was first published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this news story on another website, it was illegally copied and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this news story can be accessed at https://ledgergazette.com/2018/02/19/virtus-fund-advisers-llc-has-45-44-million-holdings-in-core-laboratories-clb.html.
Core Laboratories Company Profile
Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.
Want to see what other hedge funds are holding CLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Core Laboratories (NYSE:CLB).
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.